XML 38 R28.htm IDEA: XBRL DOCUMENT

Revenue (Tables)

3 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:


						Three Months Ended December 31, 2022
Business (in millions)						United States			International			Total
Diagnostics:
			Cytology & Perinatal			$	78.2		$	48.6		$	126.8
			Molecular Diagnostics			328.2			97.0			425.2
			Blood Screening			7.3			—			7.3
Total						$	413.7		$	145.6		$	559.3

Breast Health:
			Breast Imaging			$	212.2		$	52.2		$	264.4
			Interventional Breast Solutions			57.8			12.0			69.8

Total						$	270.0		$	64.2		$	334.2

GYN Surgical						$	123.1		$	31.0		$	154.1

Skeletal Health						$	16.8		$	9.8		$	26.6
						$	823.6		$	250.6		$	1,074.2


						Three Months Ended December 25, 2021
Business (in millions)						United States			International			Total
Diagnostics:
			Cytology & Perinatal			$	80.9		$	49.8		$	130.7
			Molecular Diagnostics			528.0			285.3			813.3
			Blood Screening			6.4			—			6.4
Total						$	615.3		$	335.1		$	950.4

Breast Health:
			Breast Imaging			$	208.9		$	73.4		$	282.3
			Interventional Breast Solutions			62.1			14.9			77.0

Total						$	271.0		$	88.3		$	359.3

GYN Surgical						$	109.3		$	25.0		$	134.3

Skeletal Health						$	16.8		$	10.3		$	27.1
						$	1,012.4		$	458.7		$	1,471.1


						Three Months Ended
Geographic Regions (in millions)						December 31, 2022			December 25, 2021
United States						$	823.6		$	1,012.4
Europe						147.4			295.1
Asia-Pacific						63.8			119.7
Rest of World						39.4			43.9
						$	1,074.2		$	1,471.1

The following table provides revenue recognized by source:


						Three Months Ended
Revenue by type (in millions)						December 31, 2022			December 25, 2021
Disposables						$	727.8		$	1,106.3
Capital equipment, components and software						158.5			197.0
Service						183.3			162.8
Other						4.6			5.0
						$	1,074.2		$	1,471.1